Life at Science We invest both in and out of the office to help you focus on building a better future. Learn more
March 5, 2026 Science Closes $230 Million Series C to Fund Commercialization of PRIMA BCI Retinal Implant and Expansion of Clinical Trials
February 20, 2026 Science Corp. and Neurosoft Bioelectronics Announce BCI Ecosystem Partnership: Science’s World-Class BCI Systems To Support Neurosoft's Pioneering Neural Data Platform
February 11, 2026 Science Founder and CEO Max Hodak Named to Time 100 Health List of the World’s Most Influential Leaders in Health
February 9, 2026 Expert Opinion: Frank Holz, M.D. on Science’s PRIMA Implant and the New Reality of Restoring Vision to Clinical Trial Patients Who Had Been Functionally Blind